A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Solid TumorStage IV Gastric Cancer

Interventions

DRUG

Paclitaxel

Oral administration on day 1,8,15 of 4-week cycle until progression, unacceptable toxicity or withdrawal of informed consent.

Trial Locations (1)

Asan Medical Center, University of Ulsan College of Medicine, Seoul